Press Releases

Common Health Disorders in Children with Down Syndrome

Down syndrome is a genetic disorder that results in mental and physical developmental delays. In addition to these disabilities, individuals diagnosed with Down syndrome often develop certain health complications. It’s important to note that health complications...

Lonza Introduces the New CytoSMARTâ„¢ 2 System for Live Cell Imaging

Lonza has introduced the CytoSMART™ 2 System, an updated version of Lonza’s popular CytoSMART™ System for live cell imaging. The CytoSMART™ 2 Device features an advanced optical system and more powerful camera unit, which enables researchers to capture higher-resolution...

Boris Johnson stresses ‘importance of the life sciences sector to the UK economy’ at TraceLink’s new European HQ launch

Foreign Secretary Boris Johnson has officially opened TraceLink’s new European headquarters in Uxbridge, UK. As the European pharmaceutical industry prepares for new serialization requirements set out in the Falsified Medicines Directive (FMD), the new headquarters will...

New In-situ Hydrolysis SPE Plates from Biotage

Biotage , a leading global supplier of solutions and technology for analytical, medicinal and peptide chemistry, is pleased to announce the launch of EVOLUTE® HYDRO, solid phase extraction plates with an integral Hydrolysis capability that enable chemists to perform...

Medical Fair Thailand Sets Record Again!

MEDICAL FAIR THAILAND 2017 concluded its most successful edition to date. It saw 830 companies from 66 countries, 18 national pavilions and country groups, and welcomed more than 9,000 quality trade visitors from over 70 countries. MEDICAL FAIR...

RedHill Biopharma Initiates Promotion of Esomeprazole Strontium Delayed-Release Capsules 49.3 mg in the U.S

RedHill Biopharma Ltd, a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer announced that it has initiated promotion of Esomeprazole Strontium Delayed-Release (DR)...

Zavante Therapeutics Announce Agreement To Assess ZOLYDâ„¢ for Lower Respiratory Tract Infections With NIAID

Zavante Therapeutics, Inc., a biopharmaceutical company focused on developing novel therapies to improve the outcomes of hospitalized patients, has signed a Clinical Trial Agreement with the National Institute of Allergy and Infectious Disease (NIAID) to evaluate Zavante’s investigational antibiotic...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read